Proliferation of microglial cells induced by 1-methyl-4-phenylpyridinium in mesencephalic cultures results from an astrocyte-dependent mechanism: Role of granulocyte macrophage colony-stimulating factor

Journal of Neurochemistry

Volumn 95, Issue 4, 2005, Pages 1069-1077

  Henze, Carmen ^a   Hartmann, Andreas ^a   Lescot, Thomas ^a   Hirsch, Etienne C ^a   Michel, Patrick P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Astrocytes; Inflammation; Microglia; MPP+; Parkinson's disease; Proliferation

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; NEUROTOXIN; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOPAMINERGIC NERVE CELL; EMBRYO; EXPOSURE; GLIA CELL; IN VITRO STUDY; INFLAMMATION; MESENCEPHALON; MICROGLIA; MITOGENESIS; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; ANTIGENS, CD11C; ASTROCYTES; CELL COUNT; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EMBRYO; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; MICROGLIA; MICROTUBULE-ASSOCIATED PROTEINS; RATS; TYROSINE 3-MONOOXYGENASE;

ANIMALIA;

EID: 28244496168     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03416.x     Document Type: Article

References (34)

1. Agid Y. (1991) Parkinson's disease: pathophysiology. Lancet 337, 1321-1324.
2. Barcia C., Sanchez Bahillo A., Fernandez-Villalba E., Bautista V., Poza Y., Poza M., Fernandez-Barreiro A., Hirsch E. C. and Herrero M. T. (2004) Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure. Glia 46, 402-409.
3. Bianchi M., Clavenna A., Bondiolotti G. P., Ferrario P. and Panerai A. E. (1997) GM-CSF affects hypothalamic neurotransmitter levels in mice: involvement of interleukin-1. Neuroreport 8, 3587-3590.
4. Breidert T., Callebert J., Heneka M. T., Landreth G., Launay J. M. and Hirsch E. C. (2002) Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease. J. Neurochem. 82, 615-624.
5. Dehmer T., Lindenau J., Haid S., Dichgans J. and Schul Z. J. B. (2000) Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo. J. Neurochem. 74, 2213-2216.
6. Di Monte D. A., Wu E. Y, Delanney L. E., Irwin I. and Langston J. W. (1992) Toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes. J. Pharmacol. Exp. Ther. 261, 44-49.
7. Du Y, Ma Z., Lin S., Dodel R. C., Gao F., Bales K. R., Triarhou L. C., Chernet E., Perry K. W., Nelson D. L. et al. (2001) Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc. Natl. Acad. Sci. USA 98, 14 669-14 674.
8. He Y, Appel S. and Le W. (2001) Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res. 909, 187-193.
9. Heikkila R. E., Manzino L., Cabbat F. S. and Duvoisin R. C. (1984) Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6- tetrahydropyridine by monoamine oxidase inhibitors. Nature 311, 467-479.
10. Hirsch E. C., Breidert T., Rousselet E., Hunot S., Hartmann A. and Michel P. P. (2003) The role of glial reaction and inflammation in Parkinson's disease. Ann. NY Acad. Sci. 991, 214-228.
11. Hunot S., Dugas N., Faucheux B., Hartmann A., Tardieu M., Debre P., Agid Y., Dugas B. and Hirsch E. C. (1999) FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J. Neurosci. 19, 3440-3447.
12. Hunot S., Vila M., Teismann P., Davis R. J., Hirsch E. C., Przedborski S., Rakic P. and Flavell R. A. (2004) JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. Proc. Natl. Acad. Sci. USA 101, 665-670.
13. Hurley S. D., O'Banion M. K., Song D. D., Arana F. S., Olschowka J. A. and Haber S. N. (2003) Microglial response is poorly correlated with neurodegeneration following chronic, low-dose MPTP administration in monkeys. Exp. Neurol. 184, 659-668.
14. Inazu M., Takeda H. and Matsumiya T. (2003) Expression and functional characterization of the extraneuronal monoamine transporter in normal human astrocytes. J. Neurochem. 84, 43-52.
15. Kawamoto J. C. and Barrett J. N. (1986) Cryopreservation of primary neurons for tissue culture. Brain Res. 384, 84-93.
16. Kay J. N. and Blum M. (2000) Differential response of ventral midbrain and striatal progenitor cells to lesions of the nigrostriatal dopaminergic projection. Dev. Neurosci. 22, 56-67.
17. Knusel B., Michel P. P., Schwaber J. S. and Hefti F. (1990) Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. J. Neurosci. 10, 558-570.
18. Koguchi K., Nakatsuji Y., Okuno T., Sawada M. and Sakoda S. (2003) Microglial cell cycle-associated proteins control microglial proliferation in vivo and in vitro and are regulated by GM-CSF and density-dependent inhibition. J. Neurosci. Res. 74, 898-905.
19. Langston J. W., Forno L. S., Tetrud J., Reeves A. G., Kaplan J. A. and Karluk D. (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann. Neurol. 46, 598-605.
20. Lee S. C., Liu W., Brosman C. F. and Dickson D. W. (1994) GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures. Clia 12, 309-318.
21. Liberatore G. T., Jackson-Lewis V., Vukosavic S., Mandir A. S., Vila M., McAuliffe W. G., Dawson V. L., Dawson T. M. and Przedborski S. (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Nat. Med. 5, 1403-1409.
22. Mao L., Lau Y. S., Petroske E. and Wang J. Q. (2001) Profound astrogenesis in the striatum of adult mice following nigrostriatal dopaminergic lesion by repeated MPTP administration. Brain Res. Dev. Brain Res. 131, 57-65.
23. McGeer P. L., Itagaki S., Boyes B. E. and McGeer E. G. (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38, 1285-1291.
24. McGeer P. L., Schwab C., Parent A. and Doudet D. (2003) Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine administration. Ann. Neurol. 54, 599-604.
25. Michel P. P. and Agid Y (1996) Chronic activation of the cyclic AMP signaling pathway promotes development and long term survival of mesencephalic dopaminergic neurons. J. Neurochem. 67, 1633-1642.
26. Michel P. P., Dandapani B. K., Knusel B., Sanchez-Ramos J. and Hefti F. (1990) Toxicity of 1-methyl-4-phenylpyridinium for rat dopaminergic neurons in culture, selectivity and irreversibility. J. Neurochem. 54, 1102-1109.
27. Mourlevat S., Troadec J. D., Ruberg M. and Michel P. P. (2003) Prevention of dopaminergic neuronal death by cyclic AMP in mixed neuronal/glial mesencephalic cultures requires the repression of presumptive astrocytes. Mol. Pharmacol. 64, 578-586.
28. Salthun-Lassalle B., Hirsch E. C., Wolfart J., Ruberg M. and Michel P. P. (2004) Rescue of mesencephalic dopaminergic neurons in culture by low-level stimulation of voltage-gated sodium channels. J. Neurosci. 24, 5922-5930.
29. Saura J., Tusell J. M. and Serratosa J. (2003) High-yield isolation of murine microglia by mild trypsinization. Glia 44, 183-189.
30. Si Q., Cosenza M., Zhao M. L., Goldstein H. and Lee S. C. (2002) GM-CSF and M-CSF modulate beta-chemokine and HIV-1 expression in microglia. Glia. 39, 174-183.
31. Sub H. S., Kim M. O. and Lee S. C. (2005) Inhibition of granulocyte-macrophage colony-stimulating factor signaling and microglial proliferation by anti-CD45RO: role of Hck tyrosine kinase and phosphatidylinositol 3-kinase/Akt. J. Immunol. 174, 2712-2719.
32. Teismann P., Tieu K., Choi D. K., Wu D. C., Naini A., Hunot S., Vila M., Jackson-Lewis V. and Przedborski S. (2003) Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc. Natl. Acad. Sci. USA 100, 5473-5478.
33. Wu D. C., Jackson-Lewis V., Vila M., Tieu K., Teismann P., Vadseth C., Choi D. K., Ischiropoulos H. and Przedborski S. (2002) Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 22, 1763-1771.
34. Zassler B., Schermer C. and Humpel C. (2003) Protein kinase C and phosphoinositol-3-kinase mediate differentiation or proliferation of slice-derived rat microglia. Pharmacology 67, 211-215.